These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6337697)

  • 1. Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone.
    Murphy GP; Beckley S; Brady MF; Chu TM; deKernion JB; Dhabuwala C; Gaeta JF; Gibbons RP; Loening SA; McKiel CF; McLeod DG; Pontes JE; Prout GR; Scardino PT; Schlegel JU; Schmidt JD; Scott WW; Slack NH; Soloway MS
    Cancer; 1983 Apr; 51(7):1264-72. PubMed ID: 6337697
    [No Abstract]   [Full Text] [Related]  

  • 2. The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate.
    Gibbons RP; Beckley S; Brady MF; Chu TM; Dekernion JB; Dhabuwala C; Gaeta JF; Loening SA; McKiel CF; McLeod DG; Pontes JE; Prout GR; Scardino PT; Schlegel JU; Schmidt JD; Scott WW; Slack NH; Soloway MS; Murphy GP
    J Surg Oncol; 1983 Jun; 23(2):133-42. PubMed ID: 6343726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of newly diagnosed stage D2 prostatic carcinoma with hormonal therapy alone, or chemotherapy agents in combination with hormones].
    Fujii A; Oka N; Miyasaki S; Higuchi A; Tomioka O; Morishita S; Yamanaka K; Itoh N; Okamoto Y; Tanaka H
    Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1656-63. PubMed ID: 1722834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
    Murphy GP; Slack NH; Mittelman A
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):34-42. PubMed ID: 6364365
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of stage D prostate cancer patients with hormones in combination with cyclophosphamide].
    Fujii A; Yasuno H; Kawaida T; Nakamura I
    Hinyokika Kiyo; 1986 Nov; 32(11):1713-7. PubMed ID: 2435128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined hormone/chemotherapy for advanced prostatic cancer].
    Komatsu H
    Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):375-85. PubMed ID: 9125860
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of hormonally unresponsive prostatic carcinoma.
    deKernion JB; Lindner A
    Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EORTC Phase III trials in prostatic cancer.
    Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
    Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer.
    Murphy GP; Huben RP; Priore R
    Urology; 1986 Jul; 28(1):36-40. PubMed ID: 3523938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orchiectomy and chemotherapy with estramustine, cis-platinum, cyclophosphamide, and 5-fluorouracil in newly diagnosed prostate cancer with bone metastases.
    Eisenkraft S; Huben RP; Pontes JE
    Urology; 1984 Jun; 23(6 Suppl):51-3. PubMed ID: 6539524
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination of hormonal and cytostatic treatment for advanced carcinoma of the prostate.
    Servadio C
    Prog Clin Biol Res; 1985; 185A():407-26. PubMed ID: 4034582
    [No Abstract]   [Full Text] [Related]  

  • 12. Estramustine phosphate with multiple cytotoxic agents in treatment of advanced prostatic cancer.
    Beckley S; Wajsman Z; Maeso E; Pontes E; Murphy G
    Urology; 1981 Dec; 18(6):592-5. PubMed ID: 7198328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemotherapy of prostatic adenocarcinoma.
    Torti FM; Carter SK
    Ann Intern Med; 1980 May; 92(5):681-9. PubMed ID: 6992675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.
    Galsky MD; Small EJ; Oh WK; Chen I; Smith DC; Colevas AD; Martone L; Curley T; Delacruz A; Scher HI; Kelly WK
    J Clin Oncol; 2005 Mar; 23(7):1439-46. PubMed ID: 15735119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data.
    Fizazi K; Le Maitre A; Hudes G; Berry WR; Kelly WK; Eymard JC; Logothetis CJ; Pignon JP; Michiels S;
    Lancet Oncol; 2007 Nov; 8(11):994-1000. PubMed ID: 17942366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A decade of experience with chemotherapy for prostate cancer.
    Slack NH; Murphy GP
    Urology; 1983 Jul; 22(1):1-7. PubMed ID: 6346631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factor analysis from EORTC trials in advanced prostatic cancer. EORTC-GU Group.
    de Voogt HJ; Suciu S; Sylvester R; Pavone-Macaluso M; Smith PH; de Pauw M
    Prog Clin Biol Res; 1990; 357():69-72. PubMed ID: 2217479
    [No Abstract]   [Full Text] [Related]  

  • 18. Leuprolide versus diethylstilbestrol for metastatic prostate cancer.
    Leuprolide Study Group
    N Engl J Med; 1984 Nov; 311(20):1281-6. PubMed ID: 6436700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
    Benson RC; Gill GM; Cummings KB
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
    [No Abstract]   [Full Text] [Related]  

  • 20. Early combined hormonal and chemotherapy for metastatic carcinoma of prostate.
    Mukamel E; Nissenkorn I; Servadio C
    Urology; 1980 Sep; 16(3):257-60. PubMed ID: 7423702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.